Published in Food and Drug Law Weekly, October 8th, 2004
The Galway facility is one of two Boston Scientific facilities that manufacture the TAXUS Express2 paclitaxel-eluting coronary stent system. The other is in Maple Grove, Minnesota.
That facility was inspected by the FDA in July, and the agency reported no observations at the conclusion of that inspection as well.
Boston Scientific is a worldwide developer, manufacturer, and marketer of medical devices whose products are used in a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.